No Data
Executive Reshuffles: CAT, LMT, and APA
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Alkermes Has Initiated Vibrance-3 Phase 2 Study Evaluating The Safety And Efficacy Of ALKS 2680 Compared To Placebo In Adults With Idiopathic Hypersomnia
Cantor Fitzgerald Reiterates Overweight on Compass Pathwaysto Overweight
Compass Pathways Analyst Ratings
Neuronetics GAAP EPS of -$0.34 Misses by $0.21, Revenue of $22.49M Misses by $6.58M
Den the Dragon :
